Market cap
$43.1m
End-of-day close multiplied by current shares on issue.
Result releasedAnnolyse analysis published
Revenue rose 20.8% and PBT grew 37.7%, but operating cash conversion fell to 50.5% of EBITDA from 55.1% as receivables grew faster than sales.
Revenue context before the current result.
EBITDA margin across covered periods.
Operating cash flow across covered periods.
Statutory profit after tax across covered periods.
Market context
These ratios pair a market close from around the result date with verified filing data. An unavailable metric means the required inputs were missing or unsuitable for comparison.
The latest close and share count context for the market price.
Market cap
$43.1m
End-of-day close multiplied by current shares on issue.
How the market price compares with recent earnings and cash-flow inputs.
P/E
Not available
Not available for this company right now.
EPS
Not available
Not available for this company right now.
PEG
Not available
Not available for this company right now.
EV/EBITDA
Not available
Not available for this company right now.
P/FCF
Not available
Not available for this company right now.
P/B
6.5x
Market value compared with latest reported equity.
Yield and investment-company valuation where supported.
Dividend yield
3.7%
Trailing dividends compared with the latest close.
Total return
Not available
Available once dividend and adjustment data are verified.
Key metrics
HY27 vs HY26
Revenue
$12.9m
Caveat: metric quality flags apply; use this value with basis context.
EBITDA
$3.7m
Caveat: metric quality flags apply; use this value with basis context.
Net profit after tax
$1.8m
Caveat: metric quality flags apply; use this value with basis context.
Net cash inflow from operating activities
$1.9m
Caveat: metric quality flags apply; use this value with basis context.
Final dividend per share
4.0c
Caveat: metric quality flags apply; use this value with basis context.
Profit before tax
$3m
Caveat: metric quality flags apply; use this value with basis context.
Cash and cash equivalents
$3m
+90.0% ↑ vs $1.6m
Total assets
$13.7m
Caveat: metric quality flags apply; use this value with basis context.
Analysis ofTAH HY27Result releasedAnnolyse analysis published
What changed
The headline growth is strong, but operating cash flow of $1.87 million (+22.9%) did not keep pace, so cash conversion fell to 50.5% of EBITDA from 55.1% in the prior comparable period.
Within the business, the aged medical care services segment contributed the larger result at $2.696 million, against $0.258 million from general practice medical services, indicating a mix increasingly weighted toward the former. Receivable days rose to 25.5 from 22.8.
On the balance sheet, cash climbed to $3.0 million from $1.579 million and gross borrowings fell 7.9% to $1.061 million, while equity rose 37.7% to $6.632 million, leaving the group in a stronger net cash position than a year earlier.
What matters
Receivable days rising to 25.5 from 22.8 is consistent with that pattern, though the data available does not establish whether this is a timing issue or a structural shift in collection terms.
The segment split shows general practice medical services contributing a markedly smaller result ($0.258 million) than aged medical care services ($2.696 million), so the earnings base is increasingly concentrated in one segment; investors should watch whether that concentration changes the group's margin profile over time.
The gap between PBT growth (37.7%) and NPAT growth (30.1%) is better explained by the bridge from group profit ($2.104 million) to owners' NPAT ($1.841 million) after a $0.263 million allocation to non-controlling interests than by tax, since the effective tax rate was broadly stable at 28.8% versus 29.1% a year earlier. This means the PBT-to-NPAT gap reflects ownership structure rather than a change in the group's tax position.
Expectations
The prior full year's reported half-year split showed the first half contributing 47.4% of full-year revenue, 48.0% of full-year EBITDA and 50.1% of full-year NPAT, but this is a reported-basis split from a different period and should not be used to infer this period's second-half trading momentum.
With no forward-work disclosure or dividend guidance for cents per share next year, the release supports a read on first-half performance but not a read on what management expects for the balance of FY27.
Quality of result
The softer cash-conversion figure and the rise in receivable days nonetheless signal that a portion of the earnings growth has not yet converted into cash in hand, which tempers how far the profit growth alone can be read as a cash-generation improvement.
The period-end working-capital balance also increased, which analytical_calculations characterises as a partial balance-proxy rather than a confirmed in-period cash-flow movement, so it should not be treated as evidence that earnings did or did not convert to cash; that judgement rests on the operating cash flow and conversion figures cited above.
Unresolved
This briefing cannot assess the underlying drivers behind any corporate activity referenced in the period, nor benchmark the result against management guidance, since no verified transaction details or forward targets were supplied.
Chat
Ask follow-up questions about Third Age Health Services's HY27 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load segment breakdown.
Open to load analytical metrics.
Open to load key metrics.
TAH 1H FY27 Unaudited company filing
HY27 / results announcementTAH 1H FY27 Unaudited Interim Financial Statements
HY27 / financial reportTAH 1H FY26 Unaudited company filing
HY26 / results announcementTAH 1H FY26 Unaudited company filing
HY26 / results releaseTAH 1H FY26 Unaudited Interim Financial Statements
HY26 / financial reportFY26 Third Age Health Annual Report
FY26 / financial reportTAH NZX Release of Annual Report 2026
FY26 / results announcementRevised date for Q1 FY27 Trading Update
FY26 / commentaryRelated insights
Compare this result's metrics with other covered NZX companies.
Cash conversion quality
This result converted 50.5% of EBITDA to operating cash flow, -4.6pp versus the prior comparable period.
Revenue growth context
Revenue growth was 20.8% for this reporting period.
Earnings quality and statutory distortions
PBT and NPAT growth diverged by 7.6pp.
Dividend coverage and payout pressure
Dividend payout versus NPAT is 21.6%.
Get the next Third Age Health Services briefing and related NZX reporting-season updates by email.